By expenditures
| Name | Title | Type |
|---|---|---|
| Lauren Everson | Director of Finance | Auditee |
| Allyson Pifko | Executive VP & Chief Operating Officer | Auditee |
| David Wiessel | Partner - Assurance Services | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 366338 | 2024 | 2025-09-15 | Ernst & Young LLP | $2.37M |
| 321719 | 2023 | 2024-09-27 | Ernst & Young | $2.06M |
| 37679 | 2022 | 2023-09-28 | Ernst & Young | $2.20M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 366338 | 2024 | 2025-09-15 | 1153118 | 2024-001 | Material Weakness | Yes | I |
| 366338 | 2024 | 2025-09-15 | 1153117 | 2024-001 | Material Weakness | Yes | I |
| 366338 | 2024 | 2025-09-15 | 1153116 | 2024-001 | Material Weakness | Yes | I |
| 366338 | 2024 | 2025-09-15 | 1153115 | 2024-001 | Material Weakness | Yes | I |
| 321719 | 2023 | 2024-09-27 | 1075348 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 1075347 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 1075346 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 1075345 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 1075344 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 498906 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 498905 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 498904 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 498903 | 2023-001 | Significant Deficiency | Yes | I |
| 321719 | 2023 | 2024-09-27 | 498902 | 2023-001 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616384 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616383 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616382 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616381 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616380 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616379 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616378 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616377 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 616376 | 2022-001 | Material Weakness | Yes | M |
| 37679 | 2022 | 2023-09-28 | 616375 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39942 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39941 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39940 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39939 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39938 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39937 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39936 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39935 | 2022-002 | Significant Deficiency | Yes | I |
| 37679 | 2022 | 2023-09-28 | 39934 | 2022-001 | Material Weakness | Yes | M |
| 37679 | 2022 | 2023-09-28 | 39933 | 2022-002 | Significant Deficiency | Yes | I |